Literature DB >> 8704320

Bestatin analogue from Streptomyces neyagawaensis SL-387.

M C Chung1, H J Lee, H K Chun, C H Lee, S I Kim, Y H Kho.   

Abstract

A bestatin analogue, (2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl-L-valine (AHPA-Val), from the culture filtrate of Streptomyces neyagawaensis SL-387 was obtained in a chemically defined medium containing DL-3-amino-3-phenylpropionic acid. AHPA-Val was 6 times (IC50 = 1.2 micrograms/ml) as strong as bestatin (IC50 = 7.0 micrograms/ml) against porcine kidney microsomal aminopeptidase N, and 4 times (5.6 micrograms/ml) as strong as bestatin (IC50 = 20.7 micrograms/ml) against aminopeptidase N of human metastatic fibrosarcoma HT1080. To the best of our knowledge, this is the first report on the microbial production of AHPA-Val.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8704320     DOI: 10.1271/bbb.60.898

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

Review 1.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

2.  Development of pyrazoline-based derivatives as aminopeptidase N inhibitors to overcome cancer invasion and metastasis.

Authors:  Jiangying Cao; Chunlong Zhao; Hang Dong; Qifu Xu; Yingjie Zhang
Journal:  RSC Adv       Date:  2021-06-17       Impact factor: 3.361

3.  Facile synthesis of 6-organyl-4-(trifluoromethyl)pyridin-2(1H)-ones and their polyfluoroalkyl-containing analogs.

Authors:  S O Kushch; M V Goryaeva; Ya V Burgart; G A Triandafilova; K O Malysheva; O P Krasnykh; N A Gerasimova; N P Evstigneeva; V I Saloutin
Journal:  Russ Chem Bull       Date:  2022-09-23       Impact factor: 1.704

4.  Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.

Authors:  Jiajia Mou; Hao Fang; Fanbo Jing; Qiang Wang; Yingzi Liu; Huawei Zhu; Luqing Shang; Xuejian Wang; Wenfang Xu
Journal:  Bioorg Med Chem       Date:  2009-05-03       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.